Clinical Trial Update: Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a samarium-based radiopharmaceutical intended to provide long-lasting analgesia for cancer-related bone pain. The study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Cancer

Drugs mentioned

• Samarium-based radiopharmaceutical for cancer-related bone pain

Snippet

Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited | Conditions: Bone Pain, Metastatic Bone Tumor | Phase 1 | Status: RECRUITING